Akèy › Metiyè › Natural Sciences Managers › Seattle, WA
Natural Sciences Managers nan Seattle, WA: Salè H-1B
31 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Seattle, WA. Salè baz medyàn ofri $157,278; mwatye mitan $128,270–$234,540.
Demann (LCA)31
Salè medyan ofri$157,278
Mwatye salè yo$128,270–$234,540
10yèm–90yèm pousantaj$98,604–$300,385
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $114,735 |
| Nivo II (kalifye) | $204,000 |
| Nivo III (eksperyans) | $145,891 |
| Nivo IV (plen kompetans) | $301,925 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Fred Hutchinson Cancer Center | 6 | $135,400 |
| Bill & Melinda Gates Foundation | 5 | $232,000 |
| Glowforge, Inc. | 3 | $235,387 |
| Gates Foundation | 3 | $303,850 |
| Adaptive Biotechnologies Corporation | 2 | $188,000 |
| Allen Institute | 2 | $132,724 |
| Seattle Children's Hospital | 2 | $127,067 |
| Varian Medical Systems, Inc. | 2 | $70,000 |
| Just-Evotec Biologics, Inc. | 1 | $176,000 |
| Gilead Sciences, Inc. | 1 | $101,782 |
| Avance Clinical LLC | 1 | $135,000 |
| Path | 1 | $143,832 |
| University of Washington | 1 | $57,264 |
| Bristol-Myers Squibb Company | 1 | $170,064 |
Tit travay
- Business Development Manager3
- Technology Chief of Staff3
- Clinical Trial Assistant2
- Senior Program Officer, Digital Agronomy1
- Director, Manufacturing Operations1
- Director, Molecular Laboratory Operations1
- CTM Associate1
- Senior Program Officer, Global Development1
- Director, Agricultural Development1
- Sr. Director, Diagnostics Strategy & Innovation1
- Deputy Director, City-Wide Inclusive Sanitation1
- Director, Developmental Immunology1
- Process Development Manager1
- Principal Clinical Research Associate1
- Senior Officer, Agriculture & Livestock Delivery Enablement1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).